News

With the addition of these two models, the Quadro FlexSift line can now handle up to 50,000kgs/hr (110,000 lbs/hr) dependent upon the product being screened. Both new models

Diquafosol was licensed for certain ophthalmic uses from Inspire and Diquas Ophthalmic Solution 3% was developed by Santen as a treatment for dry eye. Reportedly, in clinical studies

Enigma said that this is the recent patent to issue in company’s expanding portfolio of over 300 patents and patent applications. The portfolio includes patents relating to intelligent

Rezaltas is a combination drug featuring the Daiichi Sankyo-developed olmesartan medoxomil (Olmetec), a high-affinity ARB (angiotensin receptor blocker) and azelnidipine (Calblock), a long-acting CCB (calcium channel blocker) that

As part of their co-operation and as a new service to their clients in the industry, MLawGroup and WS Partners offer preparation of agreements and performance of due

Pixantrone is a new aza-anthracenedione that has distinct structural and physio-chemical properties that make its anti-tumor activity unique in this class of agents. The rapporteurs, who are assigned

The plant, in the city of Nanning in Guangxi province, has been set up in collaboration with a European pharmaceutical company for which Evonik is expected to produce

Ever since FDA has approved the TIDE trial in 2007, Avandia has been linked to an increased risk of heart attacks. Now with the regulator mulling to halt

Emerging World Pharma is an investor in generic based pharmaceutical companies manufacturing within developing nations. Emerging World Pharma said that the investment will be used to fund generic